SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000014272-23-000104
Filing Date
2023-04-27
Accepted
2023-04-27 11:56:52
Documents
101
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bmy-20230331.htm   iXBRL 10-Q 2221687
2 EXHIBIT 31.A bmyex31a_20230331.htm EX-31.A 9718
3 EXHIBIT 31.B bmyex31b_20230331.htm EX-31.B 10065
4 EXHIBIT 32.A bmyex32a_20230331.htm EX-32.A 4221
5 EXHIBIT 32.B bmyex32b_20230331.htm EX-32.B 4180
  Complete submission text file 0000014272-23-000104.txt   11012639

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmy-20230331.xsd EX-101.SCH 68565
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmy-20230331_cal.xml EX-101.CAL 128924
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmy-20230331_def.xml EX-101.DEF 322583
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmy-20230331_lab.xml EX-101.LAB 793455
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmy-20230331_pre.xml EX-101.PRE 536112
95 EXTRACTED XBRL INSTANCE DOCUMENT bmy-20230331_htm.xml XML 2208392
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-01136 | Film No.: 23853560
SIC: 2834 Pharmaceutical Preparations